TrialJournal of anesthesia2020

Thromboelastometry and a hemostasis management system are most beneficial for guiding hemostatic therapy in cardiac surgery patients with a EuroSCORE II of ≥1.83%: a randomized controlled two-step trial.

Mitsuharu Kodaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.